Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Segment Information - Financial Information Relating to Reportable Segments (Details)

Note 4 - Segment Information - Financial Information Relating to Reportable Segments (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Net sales:
Net sales	$ 114,158,000us-gaap_SalesRevenueNet	$ 95,555,000us-gaap_SalesRevenueNet	$ 334,583,000us-gaap_SalesRevenueNet	$ 265,240,000us-gaap_SalesRevenueNet
Segment operating income
Operating income	39,426,000us-gaap_OperatingIncomeLoss	45,769,000us-gaap_OperatingIncomeLoss	109,222,000us-gaap_OperatingIncomeLoss	120,904,000us-gaap_OperatingIncomeLoss
Cost recognized on sale of acquired inventory	(897,000)	(1,177,000)	(5,252,000)	(4,312,000)
Amortization expense	(6,751,000)us-gaap_AmortizationOfIntangibleAssets	(2,605,000)us-gaap_AmortizationOfIntangibleAssets	(19,338,000)us-gaap_AmortizationOfIntangibleAssets	(7,380,000)us-gaap_AmortizationOfIntangibleAssets
Acquisition related expenses	(335,000)	(395,000)	(3,906,000)	(927,000)
Corporate general and administrative expenses	(29,089,000)	(14,666,000)	(88,927,000)	(43,613,000)
Consolidated operating income	39,426,000us-gaap_OperatingIncomeLoss	45,769,000us-gaap_OperatingIncomeLoss	109,222,000us-gaap_OperatingIncomeLoss	120,904,000us-gaap_OperatingIncomeLoss
Biotechnology [Member] \| Operating Segments [Member]
Net sales:
Net sales	83,154,000	80,134,000	242,573,000	223,882,000
Segment operating income
Operating income	46,196,000	46,142,000	127,426,000	125,265,000
Consolidated operating income	46,196,000	46,142,000	127,426,000	125,265,000
Clinical Controls [Member] \| Operating Segments [Member]
Net sales:
Net sales	15,368,000	15,421,000	43,161,000	41,358,000
Segment operating income
Operating income	4,610,000	4,909,000	12,963,000	12,614,000
Consolidated operating income	4,610,000	4,909,000	12,963,000	12,614,000
Protein Platforms [Member] \| Operating Segments [Member]
Net sales:
Net sales	15,669,000		49,061,000
Segment operating income
Operating income	(1,710,000)		4,461,000	0
Consolidated operating income	(1,710,000)		4,461,000	0
Operating Segments [Member]
Segment operating income
Operating income	49,096,000	51,051,000	144,850,000	137,879,000
Consolidated operating income	49,096,000	51,051,000	144,850,000	137,879,000
Intersegment Eliminations [Member]
Net sales:
Net sales	(33,000)		(212,000)
Corporate, Non-Segment [Member]
Segment operating income
Corporate general and administrative expenses	$ (1,687,000)	$ (1,105,000)	$ (7,133,000)	$ (4,356,000)